Udenyca 6 MG/0.6 ML syringe 0.6ML
Ended Awarded
- Contract number
- SPE2DB25FXM38
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $22,842
Award facts
- Contract value 100% obligated
- $22,841.50 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a $22,841.50 firm fixed price delivery order to AmerisourceBergen Drug Corp for UDENYCA 6 mg/0.6 ml syringes on September 23, 2025, with completion expected by September 24, 2025. The award, which carries no set-aside designation, will be performed at the contractor's corporate office in Conshohocken, Pennsylvania. UDENYCA (semaglutide) is a glucagon-like peptide-1 (GLP-1) receptor agonist indicated for weight management and glycemic control, representing a critical pharmaceutical supply for military and veteran healthcare systems.
This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (contract SPE2DX), valued at $999.9 million through December 2026. As a major pharmaceutical distributor serving federal medical procurement needs, AmerisourceBergen Drug Corp maintains a comprehensive portfolio of brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains. The parent IDC supports global pharmaceutical supply for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems, positioning this delivery order as part of the company's strategic role in the DLA's Medical Supply Chain infrastructure.
Quick answers
Who was awarded contract SPE2DB25FXM38?
SPE2DB25FXM38 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 23, 2025.
How much is contract SPE2DB25FXM38 worth?
The government has obligated $22,842 on SPE2DB25FXM38.
Is contract SPE2DB25FXM38 an order under another contract?
Yes. SPE2DB25FXM38 is a delivery order under SPE2DB22D3501, an indefinite delivery contract.
Was contract SPE2DB25FXM38 competed?
The extent of competition for SPE2DB25FXM38 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award